ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

GDR Genedrive Plc

2.80
0.60 (27.27%)
12 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Genedrive Plc GDR London Ordinary Share
  Price Change Price Change % Share Price Last Trade
0.60 27.27% 2.80 16:28:57
Open Price Low Price High Price Close Price Previous Close
2.175 2.075 2.825 2.80 2.20
more quote information »
Industry Sector
PHARMACEUTICALS & BIOTECHNOLOGY

Genedrive GDR Dividends History

No dividends issued between 12 Jul 2014 and 12 Jul 2024

Top Dividend Posts

Top Posts
Posted at 12/7/2024 15:08 by kingston78
Trading volume matters. Investors are piling into GDR now. The gap must be filled for the share price to reach 3 p before progressing further. This will happen. No one can defy the law of physics.

A 5 p share price will capitalise GDR at £25 million. This is a no brainer.

The NHS is the best reference for all UK hospitals for GRD's products, and it will make it easier to sell into the US and European markets. The potential is sky high.
Posted at 12/7/2024 14:54 by kingston78
Graft Polymer has gone up by 50% each day for two days running on filing of application of patents in the US, and then revealed one big shareholder with 23% and one relatively small holder exceeding 3%. It has the same pattern as CAP-XX.

GDR will follow a similar path to those two companies above. It won't be long before GDR will have a quantum leap.
Posted at 12/7/2024 12:52 by stockhunters
hitman wow good memory but made a lot more than that on igas thanks

gdr is not like igas as two different sectors

but obvious gdr will spike on NICE announcement
Posted at 12/7/2024 07:46 by indomie1
A £50m market cap is very possible here imo, but only if NICE approval end of month comes with news on roll out/contracts. Judging by email shared on here allegedly from NICE, that seems possible now.

GDR talked on previous online presentations about potential partners like charities to help get the CYP2C19 test rolled out. If they have signed an MoU with partners to accelerate a roll out or have contracts confirmed, then share price will rerate quite considerably. Then there's the potential for positive trading updates down the line with sales momentum, possible new tests/markets not factored into share price and even a new analyst report and target share price from Finncap.

On the other hand, if GDR end up with another three year odd evidence generation plan outcome like the MT-RNR1 test, this could also tank (again!). Guess that's why it's still at these levels.

NHS seem to be real leaders globally on the rollout of pharmacogenomic testing, which is a real positive for GDR as other countries look for expertise in their own rolllouts.

Will be interesting few months here for sure with better risk/reward imo for new investors than pre recent placing. GLA DYOR
Posted at 11/7/2024 15:28 by kingston78
Some shares go up by 50% or more in a day when they announce an important news that are positive to their business, including filing of an application for a patent. That application still needs approval, and yet investors get extremely excited.

It is therefore puzzling for me as to why at a placing price of 1.5 p securing financial stability, with their products already in use in hospitals, and pending approval by NICE for another superior product, GDR's share price is stuck at 1.5 to 1.7 p for a long time until these two days at 2 p.

There is some kind of manipulation somewhere to depress the share price.

Anyway, the business case for GDR will prevail.

I am patient. Most of my portfolio are doing well, including the quiet shares. Suddenly, Capita which crawled slowly when I mentioned it not long ago at 14 p has broken through the 20 p barrier just now. By the end of August, Cleantech Lithium, which I have recommended here at 14 p will rise to 24 p. The fast moving share, Ocado, is motoring ahead.
Posted at 05/7/2024 11:52 by kingston78
When CAP-XX was on the rise investors had piled in causing it to spike. Similarly, this will occur here at GDR. I have observed that there is genuine buying interest in GDR now.

This is a winner, medically, politically and financially. Nothing is better than a leading politician standing in front of the TV camera praising GDR products at a hospital.
Posted at 02/7/2024 21:27 by billthebank
I have to say GDR has enormous potential and if you can't see that there is no more to be said. Their products are truly groundbreaking and the NHS are beginning to see that.
Peel Hunt have reduced their holding and since they sold down the share price has risen.
NICE will deliver news at the earliest 01/08/2024.I can wait.

The number of babies who can be protected from hearing loss because of GDR. BOOM!!! BUY HOLD WAIT!!!
Posted at 27/6/2024 12:01 by billthebank
Have to admit I exited a lot at 32p when Riverfort came on the scene. I have lost a lot of money here but it could have been worse. Started buying during COVID AN I still have a tranche I bought around £1.20. I intend to add next week and will be holding till this ten bags. I will be in profit when this hits 11p I hate Budd with a passion.Sooo glad he has gone.I truly love the GDR products and I sooo want this company to succeed for many reasons especially the solution to reduce deafness in new born babies!!

My major reservations is the lack of sales information.

TBH I am down here but also PXEN but feel confident in both now.

Good luck to all GDR LTHS!!!
Posted at 22/6/2024 12:23 by z1co
berty ,

You silly girl all those like myself that have bought sub 1.50p are still showing plenty of profits.

The placing price of GDR like that of POLX was massively discounted and just like POLX GDR will also rise higher strongly from the lows of 1.50p.

Share price of POLX nearly doubled this week on just holding rns's,same will happen to GDR

The other advantage for GDR shares to rise even more than POLX is there is NICE meeting on 10/07/2024 regarding the approval of CYP2C19-ID kit which will give the share price a massive boost.

You appear to be so desperate with your pathetic deramps that you're making a complete fool of yourself.
Posted at 17/6/2024 22:01 by socionomics
…an excellent post from LSE: I think he’s got it spot on:

“ Is this a silly theory?

Could PH be holding these shares on behalf of potential bidder for GDR? If they anticipate a big rise as we approach July 10th news PH cd be instructed by their client (buyer in hiding) to buy sell as they see fit both to disguise any such manoeuvre but also to take the sting out of any rise that gets under way. With so many shares they cd heavily dampen even a strong tide of interest in GDR and keep the price low in order to make a subsequent bid look more generous compared to the prevailing share price.

Is that mad or could that be one explanation of what PH are doing holding such a large stake in GDR?

When NICE news for AIHL was due GDR weren’t funded for a year. The potential market for sales is smaller than for CYP2C19 and yet the share price started to rise significantly about 10weeks before the news NICE landed.

This time around GDR has significant cash in the bank. The potential revenue from CYP2 is significantly busier and yet here we are, just three weeks away from news and we’ve had an absolutely brutal placing reducing the share price to 1.5p, massive dilution and the share price has barely risen at all.

This is AIM so one expects shenanigjns but this seems to have been a well thought out plan possibly a long time in the making and our own BoD have I’m sure been fully complicit in putting it into action.

When all said and done I don’t care as long as pis are given a chance to make some money. We know once these things become proper money making companies the pros want rid of retail investors altogether if they can and it seems as if GDR, to my mind at least, has been eyed up by someone for quite some time. Perhaps Budd was ousted because he refused to go along with it and Cheek was brought in as the yes-man to do the deed.

Dunno. All fairly wild speculation but there’s a lot that has happened over the last two or three years that doesn’t make sense here.

On the positive side the BoDs are now invested but perhaps this is their ‘bonus’ for delivering GDR into someone’s hands cheaply. Maybe the potential buyer limited them to the low amounts knowing full well they’ll get their rewards soon enough when a take over happens.

Mad?”

Your Recent History

Delayed Upgrade Clock